This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: BBRY WAG ADBE ZNGA SYMC


Research In Motion (BBRY - Get Report) was upgraded at Morgan Stanley from underweight to overweight. $22 price target. Blackberry 10 should boost overall pricing and margins, Morgan Stanley said.

Walgreen (WAG) was upgraded at JP Morgan to to overweight from neutral. $55 price target. Transforming the global supply chain with new strategic relationship, JP Morgan said.

Adobe Systems (ADBE - Get Report) downgraded at Stifel from buy to hold. Stock appears fully valued at current levels, Stifel Nicolaus said.

Zynga (ZNGA - Get Report)downgraded at BofA Merrill to neutral from buy. $3.90 price target. Risk reward less compelling, Bank of America Merrill Lynch said.

Symantec (SYMC - Get Report) downgraded at Oppenheimer from outperform to perform. Valuation call, as the stock is up 66% over the past 8 months, Oppenheimer said.

Cimarex Energy (XEC) was downgraded at FBR from outperform to market pPerform. Valuation call, based on a $72 price target, FBR Capital Markets said.

Emergent BioSolutions (EBS) was downgraded to hold at TheStreet Ratings.

AmerisourceBergen (ABC) was upgraded at Citi to buy from neutral. The deal with Walgreens will be transformational, increasing international reach and adding purchasing power, said Citigroup. Price target is $62.

AmerisourceBergen was downgraded at ISI from buy to neutral. Valuation call, based on a $54 price target, ISI Group said.

Cardinal Health (CAH) downgraded at Citi to neutral from buy. The loss of the contract with Walgreens will limit earnings growth, said Citigroup. Price target is $43.

Cardinal Health downgraded at ISI from strong buy to buy. $48.50 price target. Loss of WAG deal will cut into earnings, ISI Group said.

Ocwen (OCN) was downgraded to hold at TheStreet Ratings.

VMware (VMW) is rated new sector perform at FBN. $85 price target. Expect license growth to accelerate this year, FBN Securities said.

Cimarex Energy (XEC) downgraded at FBR from outperform to market perform. Valuation call, based on a $72 price target, FBR Capital Markets said.

Williams Partners (WPZ) initiated at UBS with a neutral rating. While the company is a dominant midstream provider, commodity sensitivity remains, said UBS. Price target is $50.


Apple (AAPL) estimates, target cut at Canaccord Genuity. Shares are now seen reaching $600. Estimates were also reduced, as the iPhone could lose market share this year, according to Canaccord Genuity.. Buy rating.

Cobalt International (CIE) price target increased at UBS to $36. The appraisal of the Shenandoah well was impressive and the North Platt oil pay was above pre-drill estimates, said UBS.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ZNGA $2.41 1.30%
ADBE $77.61 -9.60%
BBRY $6.76 2.30%
SYMC $21.01 2.80%
WAG $81.65 2.05%


Chart of I:DJI
DOW 16,790.19 +13.76 0.08%
S&P 500 1,979.92 -7.13 -0.36%
NASDAQ 4,748.3610 -32.9030 -0.69%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs